IPAB Back In The Spotlight As Repeal Bill Clears House Subcommittee
This article was originally published in The Pink Sheet Daily
House Energy and Commerce health panel votes to repeal IPAB; Ways and Means Committee plans a hearing in early March.
You may also be interested in...
CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old
CMS budget plan reprises Medicare drug rebates for dual eligibles, eliminating brand/generic patent settlements and other unsuccessful Rx proposals.
The White House has begun discussions with potential board member nominees, HHS secretary tells House Energy and Commerce Health Subcommittee.
There was lots of criticism of pharmacy benefit managers (and a fair amount of pharmaceutical manufacturers) at the oversight hearing. However, Democrats may be more cautious about preserving the benefits PBMs provide versus the downsides in developing reforms.